Good Laboratory Standards for Clinical Next-Generation Sequencing Cancer Panel Tests

Next-generation sequencing (NGS) has recently emerged as an essential component of personalized cancer medicine due to its high throughput and low per-base cost. However, no sufficient guidelines for implementing NGS as a clinical molecular pathology test are established in Korea. To ensure clinical grade quality without inhibiting adoption of NGS, a taskforce team assembled by the Korean Society of Pathologists developed laboratory guidelines for NGS cancer panel testing procedures and requirements for clinical implementation of NGS. This consensus standard proposal consists of two parts: laboratory guidelines and requirements for clinical NGS laboratories. The laboratory guidelines part addressed several important issues across multistep NGS cancer panel tests including choice of gene panel and platform, sample handling, nucleic acid management, sample identity tracking, library preparation, sequencing, analysis and reporting. Requirements for clinical NGS tests were summarized in terms of documentation, validation, quality management, and other required written policies. Together with appropriate pathologist training and international laboratory standards, these laboratory standards would help molecular pathology laboratories to successfully implement NGS cancer panel tests in clinic. In this way, the oncology community would be able to help patients to benefit more from personalized cancer medicine.

[1]  M. Knowles,et al.  Towards a Next-Generation Sequencing Diagnostic Service for Tumour Genotyping: A Comparison of Panels and Platforms , 2015, BioMed research international.

[2]  A. Marchetti,et al.  Assessing EGFR mutations. , 2006, The New England journal of medicine.

[3]  Joshua L. Deignan,et al.  ACMG clinical laboratory standards for next-generation sequencing , 2013, Genetics in Medicine.

[4]  Madhuri Hegde,et al.  Assessment of clinical analytical sensitivity and specificity of next-generation sequencing for detection of simple and complex mutations , 2013, BMC Genetics.

[5]  Birgit Funke,et al.  College of American Pathologists' laboratory standards for next-generation sequencing clinical tests. , 2015, Archives of pathology & laboratory medicine.

[6]  Nancy F. Hansen,et al.  Accurate Whole Human Genome Sequencing using Reversible Terminator Chemistry , 2008, Nature.

[7]  M. Metzker.  Sequencing technologies — the next generation , 2010, Nature Reviews Genetics.

[8]  Alexander Dobrovic,et al.  Sequence artifacts in DNA from formalin-fixed tissues: causes and strategies for minimization. , 2015, Clinical chemistry.

[9]  R. Luthra,et al.  Next-Generation Sequencing in Clinical Molecular Diagnostics of Cancer: Advantages and Challenges , 2015, Cancers.

[10]  Jason Li,et al.  Reducing sequence artifacts in amplicon-based massively parallel sequencing of formalin-fixed paraffin-embedded DNA by enzymatic depletion of uracil-containing templates. , 2013, Clinical chemistry.

[11]  Tina Hambuch,et al.  Opportunities and challenges associated with clinical diagnostic genome sequencing: a report of the Association for Molecular Pathology. , 2012, The Journal of molecular diagnostics : JMD.

[12]  Donavan T. Cheng,et al.  Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology. , 2015, The Journal of molecular diagnostics : JMD.

[13]  D. Louis.  WHO classification of tumours of the central nervous system , 2007 .

[14]  Renato Martins,et al.  Validation and implementation of targeted capture and sequencing for the detection of actionable mutation, copy number variation, and gene rearrangement in clinical cancer specimens. , 2014, The Journal of molecular diagnostics : JMD.

[15]  G. Sica,et al.  Clinical Validation and Implementation of a Targeted Next-Generation Sequencing Assay to Detect Somatic Variants in Non-Small Cell Lung, Melanoma, and Gastrointestinal Malignancies. , 2016, The Journal of molecular diagnostics : JMD.

[16]  Madhuri Hegde,et al.  Implementing Genomic Medicine in Pathology , 2013, Advances in anatomic pathology.

[17]  Daniel Nilsson,et al.  An international effort towards developing standards for best practices in analysis, interpretation and reporting of clinical genome sequencing results in the CLARITY Challenge , 2014, Genome Biology.

[18]  Takashi Nakajima,et al.  The efficacy of uracil DNA glycosylase pretreatment in amplicon-based massively parallel sequencing with DNA extracted from archived formalin-fixed paraffin-embedded esophageal cancer tissues. , 2015, Cancer genetics.

[19]  Alex M. Fichtenholtz,et al.  Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing , 2013, Nature Biotechnology.

[20]  Insuk Lee,et al.  Systematic comparison of variant calling pipelines using gold standard personal exome variants , 2015, Scientific Reports.

[21]  R. Barnard,et al.  The classification of tumours of the central nervous system. , 1982, Neuropathology and applied neurobiology.

[22]  Agus Salim,et al.  Statistical challenges associated with detecting copy number variations with next-generation sequencing , 2012, Bioinform..

[23]  J. Zook,et al.  Integrating human sequence data sets provides a resource of benchmark SNP and indel genotype calls , 2013, Nature Biotechnology.

[24]  R. Sinke,et al.  Targeted Next‐Generation Sequencing can Replace Sanger Sequencing in Clinical Diagnostics , 2013, Human mutation.

[25]  Stephen C. J. Parker,et al.  Accurate and comprehensive sequencing of personal genomes. , 2011, Genome research.

[26]  Chittibabu Guda,et al.  A Comparison of Variant Calling Pipelines Using Genome in a Bottle as a Reference , 2015, BioMed research international.

[27]  Savita Shrivastava,et al.  Validation of a next-generation sequencing assay for clinical molecular oncology. , 2014, The Journal of molecular diagnostics : JMD.

[28]  Paolo Rocco,et al.  Good laboratory practice for clinical next-generation sequencing informatics pipelines , 2015 .

[29]  Etienne Rouleau,et al.  Guidance for laboratories performing molecular pathology for cancer patients , 2014, Journal of Clinical Pathology.

[30]  William J. Howat,et al.  Tissue fixation and the effect of molecular fixatives on downstream staining procedures , 2014, Methods.

[31]  D. Hicks,et al.  The challenge and importance of standardizing pre-analytical variables in surgical pathology specimens for clinical care and translational research , 2012, Biotechnic & Histochemistry.

[32]  Marilyn M. Li,et al.  Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists. , 2017, The Journal of molecular diagnostics : JMD.

[33]  Shashikant Kulkarni,et al.  Assuring the quality of next-generation sequencing in clinical laboratory practice , 2012, Nature Biotechnology.

[34]  Etienne Rouleau,et al.  Integration of next-generation sequencing in clinical diagnostic molecular pathology laboratories for analysis of solid tumours; an expert opinion on behalf of IQN Path ASBL , 2016, Virchows Archiv.

[35]  Christina M Lockwood,et al.  Design of targeted, capture-based, next generation sequencing tests for precision cancer therapy. , 2013, Cancer genetics.

[36]  A SNP profiling panel for sample tracking in whole-exome sequencing studies , 2013, Genome Medicine.

[37]  S. Hong,et al.  Proposal of an Appropriate Decalcification Method of Bone Marrow Biopsy Specimens in the Era of Expanding Genetic Molecular Study , 2015, Journal of pathology and translational medicine.

[38]  Darragh G. McArt,et al.  Validation of Next Generation Sequencing Technologies in Comparison to Current Diagnostic Gold Standards for BRAF, EGFR and KRAS Mutational Analysis , 2013, PloS one.

[39]  K. Silverstein,et al.  CNV-RF Is a Random Forest-Based Copy Number Variation Detection Method Using Next-Generation Sequencing. , 2016, The Journal of molecular diagnostics : JMD.

[40]  Leslie Cope,et al.  Clinical validation of KRAS, BRAF, and EGFR mutation detection using next-generation sequencing. , 2014, American journal of clinical pathology.

[41]  M. Koudijs,et al.  Comparison of next-generation sequencing and mutation-specific platforms in clinical practice. , 2015, American journal of clinical pathology.